Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals
Primary Purpose
Lipidemia, Healthy
Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Viscous Fibre Blend
Psyllium
Wheat Bran
Sponsored by
About this trial
This is an interventional treatment trial for Lipidemia focused on measuring dietary fibre, Viscosity, lipids, Healthy
Eligibility Criteria
Inclusion Criteria:
-healthy individuals
Exclusion Criteria:
- regular alcohol consumption
- regular smoking
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
High Viscosity
Medium Viscosity
Low Viscosity
Arm Description
viscous fibre blend added to breakfast cereals consumed in the context of a typical North American diet for 3 weeks duration
Kellogg's Bran buds with psyllium breakfast cereal consumed in the context of a typical North American diet for 3 weeks duration
Kellogg's All Bran breakfast cereal consumed in the context of a typical North American diet for 3 weeks duration
Outcomes
Primary Outcome Measures
change in LDL cholesterol
Secondary Outcome Measures
change in total cholesterol
change in triglycerides
change in HDL cholesterol
change in apolipoprotein B
change in apolipoprotein A-1
Full Information
NCT ID
NCT03741621
First Posted
November 7, 2018
Last Updated
November 13, 2018
Sponsor
Unity Health Toronto
Collaborators
Kellogg Company, University of Toronto
1. Study Identification
Unique Protocol Identification Number
NCT03741621
Brief Title
Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals
Official Title
Viscosity Rather Than Quality of Dietary Fibre Predicts Cholesterol-lowering Effect in Healthy Individuals
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
January 1992 (Actual)
Primary Completion Date
January 1994 (Actual)
Study Completion Date
July 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Unity Health Toronto
Collaborators
Kellogg Company, University of Toronto
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
To investigate the role of fibre viscosity (low, medium, high) in lowering cholesterol in healthy individuals
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lipidemia, Healthy
Keywords
dietary fibre, Viscosity, lipids, Healthy
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
23 (Actual)
8. Arms, Groups, and Interventions
Arm Title
High Viscosity
Arm Type
Experimental
Arm Description
viscous fibre blend added to breakfast cereals consumed in the context of a typical North American diet for 3 weeks duration
Arm Title
Medium Viscosity
Arm Type
Experimental
Arm Description
Kellogg's Bran buds with psyllium breakfast cereal consumed in the context of a typical North American diet for 3 weeks duration
Arm Title
Low Viscosity
Arm Type
Experimental
Arm Description
Kellogg's All Bran breakfast cereal consumed in the context of a typical North American diet for 3 weeks duration
Intervention Type
Dietary Supplement
Intervention Name(s)
Viscous Fibre Blend
Intervention Description
High viscosity viscous fiber blend sprinkled on wheat and maize bran cereals(Bran Buds®; Kellogg Company)
Intervention Type
Dietary Supplement
Intervention Name(s)
Psyllium
Intervention Description
Bran Buds cereal (white bran and maize bran) with psyllium (Bran Buds® with PSY; Kellogg Company)
Intervention Type
Dietary Supplement
Intervention Name(s)
Wheat Bran
Intervention Description
All Bran cereal (All Bran®; Kellogg Company)
Primary Outcome Measure Information:
Title
change in LDL cholesterol
Time Frame
change from baseline after 21 days, relative to control
Secondary Outcome Measure Information:
Title
change in total cholesterol
Time Frame
change from baseline after 21 days, relative to control
Title
change in triglycerides
Time Frame
change from baseline after 21 days, relative to control
Title
change in HDL cholesterol
Time Frame
change from baseline after 21 days, relative to control
Title
change in apolipoprotein B
Time Frame
change from baseline after 21 days, relative to control
Title
change in apolipoprotein A-1
Time Frame
change from baseline after 21 days, relative to control
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
-healthy individuals
Exclusion Criteria:
regular alcohol consumption
regular smoking
12. IPD Sharing Statement
Learn more about this trial
Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals
We'll reach out to this number within 24 hrs